【発明の名称】シブトラミンおよびオルリステートを含有する医薬品組成物 - Abbott Gesell Shaft Mitt Beschlenktel Haftung Und Company Comandito Gesell Shaft

Title:

【発明の名称】シブトラミンおよびオルリステートを含有する医薬品組成物

Document Type and Number:

Japanese Patent JP2003503349

Kind Code:

A

Abstract:

A method for the treatment of co-morbid conditions associated with obesity in a human in need of such treatment which comprises administration to the human of a therapeutically effective amount of a compound of formula (I) including enantiomers and pharmaceutically acceptable salts thereof, in which R1 and R2 are independently H or methyl, and a therapeutically effective amount of a compound of formula (II) wherein the compound of formula (I) and the compound of formula (II) are administered simultaneously, separately or sequentially.

More Like This:

JPS61140549	10,11-DIHYDRO-5H-DIBENZO(A,D)CYCLOHEPTADIENE DERIVATIVE, MANUFACTURE AND DRUG
WO/2023/008921	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER CONTAINING ANTIVIRAL AGENT AND ANTIDEPRESSANT AS ACTIVE INGREDIENTS
WO/1998/009519	METHOD OF TREATING POST MENOPAUSAL DISEASES, INCLUDING OSTEOPOROSIS

Inventors:

David john heels

Application Number:

JP2001505914A

Publication Date:

January 28, 2003

Filing Date:

June 16, 2000

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Abbott Gesell Shaft Mitt Beschlenktel Haftung Und Company Comandito Gesell Shaft

International Classes:

A61K31/135; A61K31/365; A61P3/04; A61P3/06; A61P9/10; A61P9/12; A61P25/22; A61P25/24; A61P25/28; A61P25/30; A61K31/397; (IPC1-7): A61K31/135; A61K31/397; A61P3/04; A61P3/06; A61P9/10; A61P9/12; A61P25/22; A61P25/24; A61P25/28; A61P25/30

Attorney, Agent or Firm:

Toshio Yano (3 outside)

Previous Patent: JP2003503348

Next Patent: ＶＬＡ−４インヒビター化合物